About the group

We do clinical and translational studies in obesity and its cardiometabolic and renal complications, in particular type 2 diabetes through observational studies, intervention studies and large epidemiological register-based studies.

We design and conduct our own studies, perform translational research with collaborating laboratories and participate in multicenter studies initiated from academic collaborators or sponsored by the pharmaceutical industry.

Our aim is to improve prevention and treatment for type 2 diabetes.

Projects

Here is an overview of our current projects.

  • STORK Groruddalen
  • MYOGLU
  • DIASA
  • DAPHNE 
  • Epidemiology of Type 2 diabetes in Norway DIANOREG

Collaborators

Some of the group's collaborators:

  • Oslo University Hospital, Dep. of transplantation medicine, Renal section, Trond G. Jenssen, Kristian Heldal
  • Oslo University Hospital, Research Institute for Internal Medicine, Bente E. Halvorsen
  • Oslo University Hospital, Dep. of Endocrinology, Morbid Obesity and Preventive medicine, Kari Anne Sveen, Tor Ole Klemsdal
  • University of Oslo, Department of Nutrition, Frode Norheim and Marit Hjorth
  • University of Oslo, Department of Clinical Molecular Biology (EpiGen), UiO, Yvonne Böttcher
  • Norwegian School of Sport Sciences, Truls Raastad
  • Vestfold Trust Hospital, Dep. of Endocrinology and Obesity, Jøran Hjelmesæth and Dag Hofsø
  • National Public Health Institute, Div. of Chronic Diseases and Ageing, Hanne L. Gulseth and Lars Chr. Stene
  • NTNU, HUNT, Trondheim/Verdal, Bjørn Olav Åsvold
  • Western Norway University of Applied Sciences, Bergen, Marjolein M. Iversen
  • University of Glasgow, UK, Jason King and Naveed Sattar
  • University of Copenhagen, Jens Juul Holst and Gerrit van Hall